Telling the truth to the patient with cancer. A cross-cultural dialogue

Annals of the New York Academy of Sciences

Volumn 809, Issue , 1997, Pages 411-421

  Brusamolino, Ercole ^a   Surbone, Antonella ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; DOCTOR PATIENT RELATION; HUMAN; PATIENT INFORMATION; PROGNOSIS;

EID: 0030976607     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48104.x     Document Type: Article

References (22)

1. AD HOC COMMITTEE ON MEDICAL ETHICS. 1984. American College of Physicians ethics manual. Part I. History of medical ethics, the physician and the patient, the physician's relationship to other physicians, the physician and society. Ann. Intern. Med. 101: 129-137.
2. SURBONE, A. 1993. The information to cancer patient: Psychosocial and spiritual implications. Support. Care Cancer 1: 89-91.
3. SURBONE, A. 1992. Truth telling to the patient. JAMA 268: 1661-1662.
4. SURBONE, A. 1994. Informed consent and truth in medicine. Eur. J. Cancer 30A: 2189.
5. ZITTOUN, R. 1990. Patient information and participation. In Psychosocial Aspects of Oncology. J. C. Holland & R. Zittoun, Eds.: 27-44. Springer. Berlin.
6. YOURCENAR, M. 1974. Memoires d'Hadrien suivi de Carnets de notes de memories d'Hadrien. Gallimard. Paris.
7. SUCHMAN, A. L. & D. A. MATTHEWS. 1988. What makes the patient-doctor relationship therapeutic? Exploring the connexional dimension of medical care. Ann. Intern. Med. 108: 125-130.
8. THOMPSON, I. E. 1987. Fundamental ethical principles in health care. Br. Med. J. 295: 1461-1465.
9. PELLEGRINO, E. D. 1992. Is truth-telling to patients a cultural artifact? (Editorial.) JAMA 268: 1734-1735.
10. CASSEL, E. J. 1982. The nature of suffering and the goals of medicine. N. Engl. J. Med. 306: 639-645.
11. SURBONE, A. 1992. L'informazione al paziente. Il medico d'Italia. Organo Ufficiale della Federazione Nazionale dell'Ordine dei Medici Chirurghi 199: 8
12. BONADONNA, G., E. BRUSAMOLINO, P. VALAGUSSA et al. 1976. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 294: 405-410.
13. BONADONNA, G., P. VALAGUSSA, A. MOLITERNI et al. 1995. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. The results of 20 years of follow-up. N. Engl. J. Med. 332: 901-906.
14. WILLIAMS, C. J.& M. ZWITTER. 1994. Informed consent in European multicentre randomized clinical trials. Are patients really informed? Eur. J. Cancer 30A: 907-910.
15. TOBIAS, J. S. & J. HOUGHTON. 1994. Is informed consent essential for all chemotherapy studies. Eur. J. Cancer 30A: 897-899.
16. ZELEN, M. 1979. A new design for randomized clinical trials. N. Engl. J. Med. 300: 1242-1245.
17. BRUSAMOLINO, E., G. PAGNUCCO, G. CASTELLI et al. 1992. The risk of secondary myelodysplasia and acute leukemia in Hodgkin's disease is related to the combined modality therapy and to the use of nitrosourea derivatives. Proc. Am. Soc. Clin. Oncol 11: 329.
18. ANNAS, G. J. 1994. Informed consent, cancer, and truth in prognosis. N. Engl. J. Med. 330: 223-225.
19. VARIOUS AUTHORS. 1994. Informed consent, cancer, and truth in prognosis. (Correspondence.) N. Engl. J. Med. 331: 810-812.
20. MOERTEL, C. G. 1991. Off-label drug use for cancer therapy and national health care priorities. JAMA 266: 3031-3032.
21. ESPINOSA, E., M. GONZÁLES BARÓN, J. ORDOÑEZ & P. ZAMONA. 1993. The information given to the terminal patient with cancer. Eur. J. Cancer 29A: 1795-1796.
22. PELLEGRINO, E. D. 1987. Altruism, self-interest and medical ethics. JAMA 258: 1939-1940.